Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder

ClinicalTrials.gov ID: NCT04753164

Public ClinicalTrials.gov record NCT04753164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 6:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Proof-of-concept Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Placebo-controlled study to evaluate the efficacy and safety of oral ACT-539313 in the treatment of adults with moderate to severe binge eating disorder

Study identification

NCT ID
NCT04753164
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Idorsia Pharmaceuticals Ltd.
Industry
Enrollment
136 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2021 (Actual)
Primary completion
Mar 21, 2022 (Actual)
Completion
Mar 25, 2022 (Actual)
Last update posted
Mar 31, 2023

2021 – 2022

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Southern California Research Beverly Hills California 90210 —
Wr-Pri, Llc Encino California 91316 —
Collaborative Neuroscience Network (CNS) Garden Grove California 92845 —
Syrentis Clinical Research Santa Ana California 92705 —
Connecticut Clinical Research - Cromwell Cromwell Connecticut 06416 —
Clinical Neurosciences Solutions Jacksonville Florida 32256 —
Behavioral Clinical Research North Miami Florida 33161 —
Clinical Neuroscience Solutions Inc Orlando Florida 31801 —
NeuorTrials Research Inc Atlanta Georgia 30328 —
Psych Atlanta P.C. Marietta Georgia 30060 —
Capstone Clinical Research Libertyville Illinois 60048 —
Collective Medical Research Prairie Village Kansas 66208 —
Harvard Medical School - McLean Hospital Belmont Massachusetts 02478 —
Boston Clinical Trials, Inc Boston Massachusetts 02131 —
Precise Research Centers Flowood Mississippi 39232 —
St. Charles Psychiatric Associates dba Midwest research group Saint Charles Missouri 63304 —
M3 Wake Research Las Vegas Nevada 89194 —
ActivMed Practices & Research, Inc. Portsmouth New Hampshire 03081 —
ActivMed Practices & Research Portsmouth New Hampshire 03081 —
Bioscience Research Mount Kisco New York 10549 —
Manhattan Behavioral Medicine PLLC New York New York 10036 —
The Medical Research Network New York New York 10128 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Patient Priority Clinical Sites Cincinnati Ohio 45221 —
University of Cincinnati College of Medicine - Lindner Center of HOPE Mason Ohio 45040 —
North Star Medical Research, LLC Middleburg Heights Ohio 44130 —
IPS Research Company Oklahoma City Oklahoma 73106 —
Oregon Center For Clinical Inv. Portland Oregon 97214 —
Oregon Center for Clinical Investigations, Inc. (OCCI, Inc.) Salem Oregon 97304 —
Clinical Trials of Texas, Inc. (CTT) San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04753164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2023 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04753164 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →